Dr. Ada Goldsmith is a Canonsburg, Pennsylvania based Periodontics who is specialized in Periodontology. She does not accept the Medicare-approved amount. Patients will be billed for the treatment. Active license number of Dr. Ada Goldsmith is DS028576L for Periodontology in Pennsylvania. Her current practice location is 330 Morganza Rd, Canonsburg. Patients can reach her at 724-916-0111.
Dr. Ada Goldsmith is specialized in that branch of dentistry which encompasses the prevention, diagnosis and treatment of diseases of the supporting and surrounding tissues of the teeth or their substitutes and the maintenance of the health, function and esthetics of these structures and tissues.
Complete Profile:
Dr. Ada Goldsmith speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1992787642
NPI Enumeration Date:
17 Nov, 2005
NPI Last Update On:
17 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Ada Goldsmith are as mentioned below.
License Number
Specialization
State
Status
DS028576L
Periodontology
Pennsylvania
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
330 Morganza Rd, Canonsburg, Pennsylvania
Zip:
15317-8547
Phone Number:
724-916-0111
Fax Number:
724-916-0114
Patients can reach Dr. Ada Goldsmith at 330 Morganza Rd, Canonsburg, Pennsylvania or can call to book an appointment on 724-916-0111. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.